InvestSMART

Oncosil Medical Limited (ASX:OSL)

ALERT: Price-sensitive ASX Announcement for OSL
Current share price for OSL : $1.480 0.68 (85%)+
Announcement
Release
3 Feb 2026 10:52AM
Price at Release
$0.800
Full Release
download
Summary
OncoSil Medical Limited announced a capital raise of approximately $8.0 million to support its ongoing commercial expansion. This funding consists of a two-tranche placement of new shares and options to sophisticated and professional investors, expected to raise around $6.0 million, and a fully underwritten entitlement offer to raise approximately $2.0 million. The funds will be used to complete clinical trials, finish the manufacturing facility, and support sales and marketing initiatives. The capital raise is supported by substantial shareholders and directors of OncoSil, and is intended to strengthen the company's balance sheet and support key clinical, regulatory, and commercial milestones.
Key Points
  • OncoSil Medical Limited announced an $8.0 million capital raise.
  • The capital raise includes a $6.0 million placement and a $2.0 million entitlement offer.
  • Funds will support clinical trials, manufacturing, and marketing.
  • Substantial shareholders and directors support the capital raise.
  • The capital raise aims to bolster OncoSil's balance sheet and meet key strategic goals.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.